Track topics on Twitter Track topics that are important to you
A second study supports the benefit of adding an immune checkpoint inhibitor to standard chemotherapy for extensive stage, small cell lung cancer — with little additional toxicity.
Medscape Medical News
Original Article: Confirmed: OS Better With Immunotherapy in Small Cell Lung CancerNEXT ARTICLE
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...